Retrophin Inc (NASDAQ:RTRX)

24.78
Delayed Data
As of Nov 15
 +1.32 / +5.63%
Today’s Change
20.09
Today|||52-Week Range
33.00
+17.61%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close23.46
Today’s open23.19
Day’s range23.19 - 24.94
Volume198,580
Average volume (3 months)348,951
Market cap$967.7M
Data as of 4:00pm ET, 11/15/2018

Growth & Valuation

Earnings growth (last year)-19.38%
Earnings growth (this year)-842.95%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+15.98%
P/E ratioNM
Price/Sales5.27
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
BOLDAudentes Therapeutic...+0.61+2.71%
MNTAMomenta Pharmaceutic...+0.61+4.82%
ZLABZai Lab Ltd+0.57+3.37%
RYTMRhythm Pharmaceutica...+0.91+3.43%
Data as of 4:00pm ET, 11/15/2018

Financials

Next reporting dateFebruary 27, 2019
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$154.9M
Annual profit (last year)-$59.7M
Net profit margin-38.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts